Skip to content

Hospital Medicine Virtual Journal Club

Menu

Search for:

About
Archives
FAQs
How to Access Full-text Articles
How to Use
Privacy Policy and Terms of Use

Category: trends immunol

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

trends immunol • April 7, 2020

Follow Us!

Journal Club via Email

Sign up for Email updates!

The HMVJC Minute Podcast

	
	
		

Subscribe Now!


	Anchor
Apple Podcasts
Breaker
Google Podcasts
iHeartRadio
PocketCasts
Podbay
Radio Public
Spotify
TikTok
YouTube

Recent Comments

Anonymous on Things We Do for No Reason™: Obtaining Urine Testing in Older Adults With Delirium Without Signs or Symptoms of Urinary Tract Infection
agario unblocked on Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021
Ronald M. Chavin on What about tocilizumab? A retrospective study from a NYC Hospital during the COVID-19 outbreak
An Examination of Ivermectin and Other Promising Medications in the Prevention and Treatment of COVID | Compounding Corner Pharmacy, Inc. on Montelukast in Hospitalized Patients Diagnosed with COVID-19
Nathan Martin on Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19: The ACTIV-4B Randomized Clinical Trial

The HMVJC COVID Reading List

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
Elevated D-dimer and Adverse In-hospital Outcomes in COVID-19 Patients and Synergism with Hyperglycemia
Occurrence and outcomes of possible superadded infections in older adults with COVID-19-cohort study
Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: A randomized clinical trial
Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
Re-examining the widespread policy of stopping SGLT2 inhibitors during acute illness: A perspective based on the updated evidence
Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized with COVID-19: A Blinded Randomized Placebo-Controlled Trial
Ivermectin for preventing and treating COVID-19

Links

WU School of Medicine
Dept. of Medicine
Division of Hospital Medicine
Becker Medical Library
Society of Hospital Medicine
Today's Hospitalist

Editor: Robert J. Mahoney, M.D., CCS-P, SFHM

Powered by
PubMed

©2022 Washington University in St. Louis